United States Immunosuppressant Drugs Market Report 2017

November 2017 | 95 pages | ID: UC9C08BA932WEN
QYResearch

Abstracts

In this report, the United States Immunosuppressant Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest

with sales (volume), revenue (value), market share and growth rate of Immunosuppressant Drugs in these regions, from 2012 to 2022 (forecast).
United States Immunosuppressant Drugs market competition by top manufacturers/players, with Immunosuppressant Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Novartis
• Astellas Pharma
• Roche
• Pfizer
• Sanofi
• Allergan
• Bristol-Myers Squibb
• AbbVie
• Veloxis Pharmaceuticals
• GSK

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Calcineurin Inhibitors
• MTOR Inhibitors
• Anti-proliferative Agents
• Steroids
• Antibodies

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Kidney
• Bone Marrow
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Immunosuppressant Drugs Market Report 2017

1 IMMUNOSUPPRESSANT DRUGS OVERVIEW

1.1 Product Overview and Scope of Immunosuppressant Drugs
1.2 Classification of Immunosuppressant Drugs by Product Category
  1.2.1 United States Immunosuppressant Drugs Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Immunosuppressant Drugs Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Calcineurin Inhibitors
  1.2.4 MTOR Inhibitors
  1.2.5 Anti-proliferative Agents
  1.2.6 Steroids
  1.2.7 Antibodies
1.3 United States Immunosuppressant Drugs Market by Application/End Users
  1.3.1 United States Immunosuppressant Drugs Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Kidney
  1.3.3 Bone Marrow
  1.3.4 Others
1.4 United States Immunosuppressant Drugs Market by Region
  1.4.1 United States Immunosuppressant Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Immunosuppressant Drugs Status and Prospect (2012-2022)
  1.4.3 Southwest Immunosuppressant Drugs Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Immunosuppressant Drugs Status and Prospect (2012-2022)
  1.4.5 New England Immunosuppressant Drugs Status and Prospect (2012-2022)
  1.4.6 The South Immunosuppressant Drugs Status and Prospect (2012-2022)
  1.4.7 The Midwest Immunosuppressant Drugs Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Immunosuppressant Drugs (2012-2022)
  1.5.1 United States Immunosuppressant Drugs Sales and Growth Rate (2012-2022)
  1.5.2 United States Immunosuppressant Drugs Revenue and Growth Rate (2012-2022)

2 UNITED STATES IMMUNOSUPPRESSANT DRUGS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Immunosuppressant Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Immunosuppressant Drugs Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Immunosuppressant Drugs Average Price by Players/Suppliers (2012-2017)
2.4 United States Immunosuppressant Drugs Market Competitive Situation and Trends
  2.4.1 United States Immunosuppressant Drugs Market Concentration Rate
  2.4.2 United States Immunosuppressant Drugs Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Immunosuppressant Drugs Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES IMMUNOSUPPRESSANT DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Immunosuppressant Drugs Sales and Market Share by Region (2012-2017)
3.2 United States Immunosuppressant Drugs Revenue and Market Share by Region (2012-2017)
3.3 United States Immunosuppressant Drugs Price by Region (2012-2017)

4 UNITED STATES IMMUNOSUPPRESSANT DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Immunosuppressant Drugs Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Immunosuppressant Drugs Revenue and Market Share by Type (2012-2017)
4.3 United States Immunosuppressant Drugs Price by Type (2012-2017)
4.4 United States Immunosuppressant Drugs Sales Growth Rate by Type (2012-2017)

5 UNITED STATES IMMUNOSUPPRESSANT DRUGS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Immunosuppressant Drugs Sales and Market Share by Application (2012-2017)
5.2 United States Immunosuppressant Drugs Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES IMMUNOSUPPRESSANT DRUGS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Novartis
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Immunosuppressant Drugs Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Novartis Immunosuppressant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Astellas Pharma
  6.2.2 Immunosuppressant Drugs Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Astellas Pharma Immunosuppressant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Roche
  6.3.2 Immunosuppressant Drugs Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Roche Immunosuppressant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Pfizer
  6.4.2 Immunosuppressant Drugs Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Pfizer Immunosuppressant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Sanofi
  6.5.2 Immunosuppressant Drugs Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Sanofi Immunosuppressant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Allergan
  6.6.2 Immunosuppressant Drugs Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Allergan Immunosuppressant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Bristol-Myers Squibb
  6.7.2 Immunosuppressant Drugs Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Bristol-Myers Squibb Immunosuppressant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 AbbVie
  6.8.2 Immunosuppressant Drugs Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 AbbVie Immunosuppressant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Veloxis Pharmaceuticals
  6.9.2 Immunosuppressant Drugs Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Veloxis Pharmaceuticals Immunosuppressant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 GSK
  6.10.2 Immunosuppressant Drugs Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 GSK Immunosuppressant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview

7 IMMUNOSUPPRESSANT DRUGS MANUFACTURING COST ANALYSIS

7.1 Immunosuppressant Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Immunosuppressant Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Immunosuppressant Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Immunosuppressant Drugs Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES IMMUNOSUPPRESSANT DRUGS MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Immunosuppressant Drugs Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Immunosuppressant Drugs Sales Volume Forecast by Type (2017-2022)
11.3 United States Immunosuppressant Drugs Sales Volume Forecast by Application (2017-2022)
11.4 United States Immunosuppressant Drugs Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Immunosuppressant Drugs
Figure United States Immunosuppressant Drugs Market Size (K MT) by Type (2012-2022)
Figure United States Immunosuppressant Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Calcineurin Inhibitors Product Picture
Figure MTOR Inhibitors Product Picture
Figure Anti-proliferative Agents Product Picture
Figure Steroids Product Picture
Figure Antibodies Product Picture
Figure United States Immunosuppressant Drugs Market Size (K MT) by Application (2012-2022)
Figure United States Sales Market Share of Immunosuppressant Drugs by Application in 2016
Figure Kidney Examples
Table Key Downstream Customer in Kidney
Figure Bone Marrow Examples
Table Key Downstream Customer in Bone Marrow
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Immunosuppressant Drugs Market Size (Million USD) by Region (2012-2022)
Figure The West Immunosuppressant Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Immunosuppressant Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Immunosuppressant Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Immunosuppressant Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Immunosuppressant Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Immunosuppressant Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Immunosuppressant Drugs Sales (K MT) and Growth Rate (2012-2022)
Figure United States Immunosuppressant Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Immunosuppressant Drugs Market Major Players Product Sales Volume (K MT) (2012-2017)
Table United States Immunosuppressant Drugs Sales (K MT) of Key Players/Suppliers (2012-2017)
Table United States Immunosuppressant Drugs Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Immunosuppressant Drugs Sales Share by Players/Suppliers
Figure 2017 United States Immunosuppressant Drugs Sales Share by Players/Suppliers
Figure United States Immunosuppressant Drugs Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Immunosuppressant Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Immunosuppressant Drugs Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Immunosuppressant Drugs Revenue Share by Players/Suppliers
Figure 2017 United States Immunosuppressant Drugs Revenue Share by Players/Suppliers
Table United States Market Immunosuppressant Drugs Average Price (USD/MT) of Key Players/Suppliers (2012-2017)
Figure United States Market Immunosuppressant Drugs Average Price (USD/MT) of Key Players/Suppliers in 2016
Figure United States Immunosuppressant Drugs Market Share of Top 3 Players/Suppliers
Figure United States Immunosuppressant Drugs Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Immunosuppressant Drugs Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Immunosuppressant Drugs Product Category
Table United States Immunosuppressant Drugs Sales (K MT) by Region (2012-2017)
Table United States Immunosuppressant Drugs Sales Share by Region (2012-2017)
Figure United States Immunosuppressant Drugs Sales Share by Region (2012-2017)
Figure United States Immunosuppressant Drugs Sales Market Share by Region in 2016
Table United States Immunosuppressant Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Immunosuppressant Drugs Revenue Share by Region (2012-2017)
Figure United States Immunosuppressant Drugs Revenue Market Share by Region (2012-2017)
Figure United States Immunosuppressant Drugs Revenue Market Share by Region in 2016
Table United States Immunosuppressant Drugs Price (USD/MT) by Region (2012-2017)
Table United States Immunosuppressant Drugs Sales (K MT) by Type (2012-2017)
Table United States Immunosuppressant Drugs Sales Share by Type (2012-2017)
Figure United States Immunosuppressant Drugs Sales Share by Type (2012-2017)
Figure United States Immunosuppressant Drugs Sales Market Share by Type in 2016
Table United States Immunosuppressant Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Immunosuppressant Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Immunosuppressant Drugs by Type (2012-2017)
Figure Revenue Market Share of Immunosuppressant Drugs by Type in 2016
Table United States Immunosuppressant Drugs Price (USD/MT) by Types (2012-2017)
Figure United States Immunosuppressant Drugs Sales Growth Rate by Type (2012-2017)
Table United States Immunosuppressant Drugs Sales (K MT) by Application (2012-2017)
Table United States Immunosuppressant Drugs Sales Market Share by Application (2012-2017)
Figure United States Immunosuppressant Drugs Sales Market Share by Application (2012-2017)
Figure United States Immunosuppressant Drugs Sales Market Share by Application in 2016
Table United States Immunosuppressant Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Immunosuppressant Drugs Sales Growth Rate by Application (2012-2017)
Table Novartis Basic Information List
Table Novartis Immunosuppressant Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Novartis Immunosuppressant Drugs Sales Growth Rate (2012-2017)
Figure Novartis Immunosuppressant Drugs Sales Market Share in United States (2012-2017)
Figure Novartis Immunosuppressant Drugs Revenue Market Share in United States (2012-2017)
Table Astellas Pharma Basic Information List
Table Astellas Pharma Immunosuppressant Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Astellas Pharma Immunosuppressant Drugs Sales Growth Rate (2012-2017)
Figure Astellas Pharma Immunosuppressant Drugs Sales Market Share in United States (2012-2017)
Figure Astellas Pharma Immunosuppressant Drugs Revenue Market Share in United States (2012-2017)
Table Roche Basic Information List
Table Roche Immunosuppressant Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Roche Immunosuppressant Drugs Sales Growth Rate (2012-2017)
Figure Roche Immunosuppressant Drugs Sales Market Share in United States (2012-2017)
Figure Roche Immunosuppressant Drugs Revenue Market Share in United States (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Immunosuppressant Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Pfizer Immunosuppressant Drugs Sales Growth Rate (2012-2017)
Figure Pfizer Immunosuppressant Drugs Sales Market Share in United States (2012-2017)
Figure Pfizer Immunosuppressant Drugs Revenue Market Share in United States (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Immunosuppressant Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Sanofi Immunosuppressant Drugs Sales Growth Rate (2012-2017)
Figure Sanofi Immunosuppressant Drugs Sales Market Share in United States (2012-2017)
Figure Sanofi Immunosuppressant Drugs Revenue Market Share in United States (2012-2017)
Table Allergan Basic Information List
Table Allergan Immunosuppressant Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Allergan Immunosuppressant Drugs Sales Growth Rate (2012-2017)
Figure Allergan Immunosuppressant Drugs Sales Market Share in United States (2012-2017)
Figure Allergan Immunosuppressant Drugs Revenue Market Share in United States (2012-2017)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Immunosuppressant Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Immunosuppressant Drugs Sales Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Immunosuppressant Drugs Sales Market Share in United States (2012-2017)
Figure Bristol-Myers Squibb Immunosuppressant Drugs Revenue Market Share in United States (2012-2017)
Table AbbVie Basic Information List
Table AbbVie Immunosuppressant Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure AbbVie Immunosuppressant Drugs Sales Growth Rate (2012-2017)
Figure AbbVie Immunosuppressant Drugs Sales Market Share in United States (2012-2017)
Figure AbbVie Immunosuppressant Drugs Revenue Market Share in United States (2012-2017)
Table Veloxis Pharmaceuticals Basic Information List
Table Veloxis Pharmaceuticals Immunosuppressant Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Veloxis Pharmaceuticals Immunosuppressant Drugs Sales Growth Rate (2012-2017)
Figure Veloxis Pharmaceuticals Immunosuppressant Drugs Sales Market Share in United States (2012-2017)
Figure Veloxis Pharmaceuticals Immunosuppressant Drugs Revenue Market Share in United States (2012-2017)
Table GSK Basic Information List
Table GSK Immunosuppressant Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure GSK Immunosuppressant Drugs Sales Growth Rate (2012-2017)
Figure GSK Immunosuppressant Drugs Sales Market Share in United States (2012-2017)
Figure GSK Immunosuppressant Drugs Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Immunosuppressant Drugs
Figure Manufacturing Process Analysis of Immunosuppressant Drugs
Figure Immunosuppressant Drugs Industrial Chain Analysis
Table Raw Materials Sources of Immunosuppressant Drugs Major Players/Suppliers in 2016
Table Major Buyers of Immunosuppressant Drugs
Table Distributors/Traders List
Figure United States Immunosuppressant Drugs Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
Figure United States Immunosuppressant Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Immunosuppressant Drugs Price (USD/MT) Trend Forecast (2017-2022)
Table United States Immunosuppressant Drugs Sales Volume (K MT) Forecast by Type (2017-2022)
Figure United States Immunosuppressant Drugs Sales Volume (K MT) Forecast by Type (2017-2022)
Figure United States Immunosuppressant Drugs Sales Volume (K MT) Forecast by Type in 2022
Table United States Immunosuppressant Drugs Sales Volume (K MT) Forecast by Application (2017-2022)
Figure United States Immunosuppressant Drugs Sales Volume (K MT) Forecast by Application (2017-2022)
Figure United States Immunosuppressant Drugs Sales Volume (K MT) Forecast by Application in 2022
Table United States Immunosuppressant Drugs Sales Volume (K MT) Forecast by Region (2017-2022)
Table United States Immunosuppressant Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States Immunosuppressant Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States Immunosuppressant Drugs Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources